Indo Us Bio-Tech - News

NSE: INDOUS | BSE: 541304

₹73.54

₹-4.82 (-6.15%)

As on 30-Oct-2026IST

Market cap

₹148 Cr

Revenue (TTM)

₹97 Cr

P/E Ratio

34.1

P/B Ratio

1.6

Div. Yield

0 %

Annual Reports

Annual Reports

2026

Annual Reports

2025

Annual Reports

2024

Annual Reports

2023

Annual Reports

2022

Annual Reports

2021

Annual Reports

2020

Annual Reports

2019

Annual Reports

2018

Annual Reports

2017

Announcements

View Announcements

Recent

Important

Results- Financial Results For September 30 2026

30-Oct-2026

Board Meeting Outcome for Outcome Of Board Meeting Held On Friday October 30 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.

30-Oct-2026

Board Meeting Intimation for Considering Approving And Take On Record The Un-Audited Standalone Financial Result Of The Company For The Quarter And Half Year Ended 30Th September 2026.

24-Oct-2026

Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding Directors Cum Promoters And Other Promoter Visit To China.

23-Oct-2026

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

14-Oct-2026

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

02-Oct-2026

Shareholder Meeting / Postal Ballot-Outcome of AGM

30-Sep-2026

Closure of Trading Window

28-Sep-2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Sep-2026

Reg. 34 (1) Annual Report.

05-Sep-2026